These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16538192)

  • 1. Diagnostic imaging of carcinoid metastases to the abdomen and pelvis.
    Cwikła JB; Buscombe JR; Caplin ME; Watkinson AF; Walecki J; Gorczyca-Wiśniewska E; Hilson AJ
    Med Sci Monit; 2004 Jun; 10 Suppl 3():9-16. PubMed ID: 16538192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
    Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T
    Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver metastasis from carcinoid: diagnostic imaging].
    De Santis M; Santini D; Alborino S; Carubbi F; Romagnoli R
    Radiol Med; 1996 Nov; 92(5):594-9. PubMed ID: 9036451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
    Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
    J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flush symptoms caused by a mesenteric carcinoid without liver metastases.
    Sonnet S; Wiesner W
    JBR-BTR; 2002; 85(5):254-6. PubMed ID: 12463502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-111 DTPA octreotide scintigraphy and intraoperative gamma probe detection in the diagnosis and treatment of residual lymph node metastases of a rectal carcinoid tumor.
    Banzo J; Vidal-Sicat S; Prats E; Galofré G; Razola P; Mañé S; Ubieto MA; Abós MD
    Clin Nucl Med; 2005 May; 30(5):308-11. PubMed ID: 15827397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids.
    Kisker O; Weinel RJ; Geks J; Zacara F; Joseph K; Rothmund M
    World J Surg; 1996 Feb; 20(2):162-7. PubMed ID: 8661812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
    Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
    AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
    Hubalewska-Dydejczyk A; Fröss-Baron K; Mikołajczak R; Maecke HR; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybiński P; Kulig J
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1123-33. PubMed ID: 16721571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreoscan in patients with bronchial carcinoid tumours.
    Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
    Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
    Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
    Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
    J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
    Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET.
    Yüksel M; Eziddin S; Ladwein E; Haas S; Biersack HJ
    Ann Nucl Med; 2005 Oct; 19(7):611-5. PubMed ID: 16363628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
    Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
    Hoegerle S; Altehoefer C; Ghanem N; Koehler G; Waller CF; Scheruebl H; Moser E; Nitzsche E
    Radiology; 2001 Aug; 220(2):373-80. PubMed ID: 11477239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.